Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Medicine, Hyperkalemia, Kidney disease, Internal medicine, Intensive care medicine, and Clinical endpoint.
Long-Term Effects of Patiromer for Hyperkalaemia Treatment in Patients with Mild Heart Failure and Diabetic Nephropathy on Angiotensin-Converting Enzymes/Angiotensin Receptor Blockers: Results from AMETHYST-DN
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
Effect of Patiromer on Reducing Serum Potassium and Preventing Recurrent Hyperkalaemia in Patients with Heart Failure and Chronic Kidney Disease on Raas Inhibitors
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia
Patiromer Reduces Serum K+ in Hyperkalemic Patients with HF and CKD on RAAS Inhibitors: Results from OPAL-HK and AMETHYST-DN
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors